Todd Meyerrose is a distinguished professional in the biotechnology and venture capital sectors, serving as the Co-Founder of Lexent Bio, which focuses on liquid biopsy detection for treatment response, since its inception in 2016. As a Founding Partner at BioMed Ventures, Todd has invested in various innovative companies across multiple domains, including precision medicine, clinical pharmacy telemedicine, and drug discovery. In addition to venture capital activities, Todd holds the position of Consulting Associate Professor at Stanford University, where responsibilities include co-directing the Biotechnology Business and Finance course. Todd's expertise is also sought by several organizations as an advisor and investor, contributing valuable insights to multiple companies within the healthcare landscape. Educationally, Todd holds dual PhDs in Molecular Cell Biology and Craniofacial Biology and Development, complementing a strong foundational knowledge in biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices